3/31/2024 | 30049099 | 272697126669 PRESCRIBED MEDICINE - DIABETES HEART AND CHOL | XXXXXXXXXX | 0.4 | KG | 102.744604 | United Arab Emirates | LPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRID 15MG 0.450 KGS NON COMMERCIAL | XXXXXXXXXX | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRIDE 15 MG 0.450 KGS NON COMMERCIAL | XXXXXXXXXX | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- 2004374/ OPDIVO NIVOLUMIB 40,100MG10ML 0.900 KGS NON COMMERCIAL | XXXXXXXXXX | 0.9 | KG | 2132.676258 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE FOR HOSPITAL USE. | XXXXXXXXXX | 30 | KG | 4598.705035 | United Arab Emirates | LPAF |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1002866/ ADCETRIS BRENTUXIMIB VEDOTINE 50 MG 0.680 KGS NON COMMERCIAL | XXXXXXXXXX | 0.68 | KG | 28.776978 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED AS PER ACCESS PROGRAM- 2004374 OPDIVO NIVOLUMIB 40/MG 10ML WEIGHT 0.300 KGS NON COMMERCIAL | XXXXXXXXXX | 0.3 | KG | 759.172661 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1002866/ ADCETRIS BRENTUXIMIB VEDOTINE 50 MG 0.680 KGS NON COMMERCIAL | XXXXXXXXXX | 0.68 | KG | 28.776978 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE FOR HOSPITAL USE. | XXXXXXXXXX | 30 | KG | 4598.705035 | United Arab Emirates | LPAF |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRID 15MG 0.450 KGS NON COMMERCIAL | XXXXXXXXXX | 0.45 | KG | 28.057553 | United Kingdom | KPFI |